$CDXS Income Statement | Understand Stock

$CDXS

$1.26 -$0.02 (1.56%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Research and development revenue ($1,955, $900 and $0 from a related party)
Product revenue
Research and development revenue
Total revenues

Costs and operating expenses:
Cost of product revenue
Research and development
Selling, general and administrative
Restructuring charges
Asset impairment and other charges
Total costs and operating expenses
Loss from operations
Interest income
Interest and other expense, net
Loss before income taxes
Provision for income taxes
Net loss
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted average common stock shares used in computing net loss per share, basic (in shares)
Weighted average common stock shares used in computing net loss per share, diluted (in shares)

Comments